Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.
Landgren O, Prior TJ, Masterson T, Heuck C, Bueno OF, Dash AB, Einsele H, Goldschmidt H, Knop S, Li C, Mellqvist UH, McFadden I, Oprea C, Ross JA, Talpes M, Hydren JR, Ahlstrom JM, Kazandjian D, Weinhold N, Zhang R, Stetler-Stevenson M, Marti G, Devlin SM. Landgren O, et al. Among authors: mcfadden i. Blood. 2024 Jul 25;144(4):359-367. doi: 10.1182/blood.2024024371. Blood. 2024. PMID: 38768337
Futureproofing Europe's forests.
McFadden IR. McFadden IR. Nat Ecol Evol. 2024 Jun;8(6):1064-1065. doi: 10.1038/s41559-024-02408-6. Nat Ecol Evol. 2024. PMID: 38684740 No abstract available.
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.
Perrot A, Delimpasi S, Spanoudakis E, Frølund U, Belotti A, Oriol A, Moreau P, McFadden I, Xia Q, Arora M, Dimopoulos MA. Perrot A, et al. Among authors: mcfadden i. Leuk Lymphoma. 2024 Jun;65(6):833-842. doi: 10.1080/10428194.2024.2322030. Epub 2024 Mar 18. Leuk Lymphoma. 2024. PMID: 38497533 Free article. Clinical Trial.
Warming underpins community turnover in temperate freshwater and terrestrial communities.
Khaliq I, Rixen C, Zellweger F, Graham CH, Gossner MM, McFadden IR, Antão L, Brodersen J, Ghosh S, Pomati F, Seehausen O, Roth T, Sattler T, Supp SR, Riaz M, Zimmermann NE, Matthews B, Narwani A. Khaliq I, et al. Among authors: mcfadden ir. Nat Commun. 2024 Mar 1;15(1):1921. doi: 10.1038/s41467-024-46282-z. Nat Commun. 2024. PMID: 38429327 Free PMC article.
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.
Weisel K, Dimopoulos MA, Beksac M, Leleu X, Richter J, Heeg B, Patel S, Majer I, McFadden I, Mikhael J. Weisel K, et al. Among authors: mcfadden i. Leuk Lymphoma. 2024 Apr;65(4):481-492. doi: 10.1080/10428194.2023.2300051. Epub 2024 Feb 12. Leuk Lymphoma. 2024. PMID: 38345269 Free article. Clinical Trial.
The geography of climate and the global patterns of species diversity.
Coelho MTP, Barreto E, Rangel TF, Diniz-Filho JAF, Wüest RO, Bach W, Skeels A, McFadden IR, Roberts DW, Pellissier L, Zimmermann NE, Graham CH. Coelho MTP, et al. Among authors: mcfadden ir. Nature. 2023 Oct;622(7983):537-544. doi: 10.1038/s41586-023-06577-5. Epub 2023 Sep 27. Nature. 2023. PMID: 37758942 Free PMC article.
Linking human impacts to community processes in terrestrial and freshwater ecosystems.
McFadden IR, Sendek A, Brosse M, Bach PM, Baity-Jesi M, Bolliger J, Bollmann K, Brockerhoff EG, Donati G, Gebert F, Ghosh S, Ho HC, Khaliq I, Lever JJ, Logar I, Moor H, Odermatt D, Pellissier L, de Queiroz LJ, Rixen C, Schuwirth N, Shipley JR, Twining CW, Vitasse Y, Vorburger C, Wong MKL, Zimmermann NE, Seehausen O, Gossner MM, Matthews B, Graham CH, Altermatt F, Narwani A. McFadden IR, et al. Ecol Lett. 2023 Feb;26(2):203-218. doi: 10.1111/ele.14153. Epub 2022 Dec 22. Ecol Lett. 2023. PMID: 36560926 Free PMC article. Review.
20 results